Nervous System

POTS and dysautonomia: when the autonomic nervous system misfires

By Hussain Sharifi · 15 min read · Reviewed May 2026

POTS, postural orthostatic tachycardia syndrome, is a disorder of the autonomic nervous system in which your heart rate jumps by at least 30 beats per minute (40 in teenagers) within ten minutes of standing up, without the large drop in blood pressure that defines simple fainting. It causes dizziness, palpitations, brain fog, fatigue and exercise intolerance that ease when you lie down. It is real, often disabling, frequently mistaken for anxiety, and most of it can be assessed and managed in UK primary care.

Key facts

On this page
  1. What POTS actually is
  2. The symptoms, and why they cluster
  3. Subtypes: hyperadrenergic, hypovolaemic, neuropathic
  4. How it is diagnosed: active stand and tilt-table
  5. Long COVID and connective tissue
  6. Why it gets misdiagnosed as anxiety
  7. Evidence-based management
  8. Getting help in the UK

What POTS actually is

Standing up is a small physiological emergency. Gravity pulls roughly half a litre of blood down into your legs and abdomen, and your autonomic nervous system has to respond in seconds: tightening blood vessels and nudging the heart so blood pressure holds and your brain stays perfused. In POTS that reflex misfires. Blood pressure is usually held, but only at the cost of a large, sustained surge in heart rate. Your body keeps you upright by revving the engine, and you feel every bit of it.1

The formal criteria, set out in the 2015 Heart Rhythm Society expert consensus statement, are precise. POTS requires a sustained increase in heart rate of at least 30 bpm within ten minutes of standing or head-up tilt (at least 40 bpm in those aged 12 to 19), without orthostatic hypotension (a fall in blood pressure of more than 20/10 mmHg). Symptoms must be present for at least six months and ease on lying down, and other causes of a fast heart rate, such as anaemia, an overactive thyroid, dehydration, blood loss or relevant medicines, must be excluded.1 That last point matters: POTS is partly a diagnosis of exclusion, which is why a careful work-up is worth the wait.

POTS is best understood as a syndrome, a recognisable pattern with several possible underlying mechanisms, rather than a single disease with one cause. It sits within the broader family of dysautonomia, the umbrella term for autonomic nervous system dysfunction, which also includes vasovagal syncope and orthostatic hypotension. For the wider picture of how the autonomic "accelerator and brake" system works, our piece on the vagus nerve and autonomic balance sets out the architecture POTS disrupts.

The symptoms, and why they cluster

The hallmark is that symptoms come on or worsen when upright and improve when lying down. Patients describe a racing or pounding heart on standing, light-headedness, visual greying, shakiness, and sometimes near-fainting. Many also report a heavy, "concrete-legged" feeling and blood pooling that turns the feet and lower legs dusky or purple when standing still.1

What surprises people is how much of POTS is not about the heart at all. Brain fog, fatigue and exercise intolerance are among the most disabling features, and they are easy to dismiss as stress or low mood. Cognitive symptoms, difficulty concentrating, word-finding trouble and mental fatigue, are well documented and partly reflect the brain being intermittently underperfused on standing.2 Gut symptoms, bladder symptoms, temperature dysregulation, sweating changes and poor sleep are all common too, because the autonomic nervous system runs all of those systems at once. If brain fog is your dominant complaint, our explainer on why you cannot think straight covers the wider differential.

Subtypes: hyperadrenergic, hypovolaemic, neuropathic

Researchers describe several overlapping POTS "subtypes", grouped by the dominant mechanism. These are useful for thinking about treatment, but they are not clean boxes: most patients show features of more than one, and not every specialist formally assigns a subtype.7

The commonly described POTS subtypes and what tends to characterise each. Overlap is the rule, not the exception.
SubtypeDominant problemTypical clues
HyperadrenergicSympathetic nervous system overdriveStanding plasma noradrenaline often >600 pg/mL, a rise in systolic blood pressure on standing, tremor, anxiety-like surges, flushing, migraine.7
HypovolaemicLow circulating blood volumeReduced plasma and red-cell volume; often paradoxically low renin and aldosterone for the degree of low volume.7
NeuropathicPatchy small-fibre autonomic nerve damagePoor blood-vessel tightening in the legs, marked lower-limb pooling; may show small-fibre neuropathy on testing.7

There is also active research into an autoimmune contribution, especially after infections. Studies have found autoantibodies targeting adrenergic and muscarinic receptors in a subset of patients, which could in theory drive both the failure of vessels to constrict and the compensatory tachycardia.8 This is interesting observational and mechanistic science, but it is not yet a routine test or a basis for immune treatment outside research, and the commercial antibody panels sometimes marketed to patients are not validated for diagnosis. Treat the autoimmune story as a promising lead, not settled fact.

How it is diagnosed: the active stand and tilt-table tests

The core test is simpler than most people expect, and can often be done in a GP surgery. In an active stand test, your heart rate and blood pressure are measured after lying flat for at least five minutes, then again at intervals (typically about 2, 5 and 10 minutes) after you stand up. A sustained heart-rate rise meeting the threshold, with no big blood-pressure drop, supports the diagnosis.9

You do not always need a tilt-table. UK guidance is clear that POTS can be diagnosed in primary care with an active stand test, and that a tilt-table test is not required for most people.9 A tilt-table, where you are strapped to a motorised table and tilted head-up while monitored, is reserved for uncertain cases or specialist assessment. A normal ECG and examination usually mean no cardiology referral is needed unless an arrhythmia is suspected.9

Because POTS is partly defined by excluding other causes, expect basic tests: a 12-lead ECG, full blood count, thyroid function and electrolytes, sometimes with a Holter (24-hour ECG) monitor if the rhythm itself is in doubt.9 To understand those blood tests before your appointment, our guide to the full blood count is a good primer.

Long COVID and connective tissue: the two big associations

Two links have transformed how often POTS is recognised. The first is long COVID. Cardiovascular autonomic dysfunction is one of the better-characterised features of post-acute COVID-19, and POTS has emerged in a substantial minority of highly symptomatic patients: a 2025 study in Circulation: Arrhythmia and Electrophysiology found around 30% of such a cohort met POTS criteria on testing.4 This can follow mild infections and is unrelated to how severe the original illness was. A useful detail for the worried: post-viral POTS often improves over months to a couple of years with proper management, though not for everyone.10

The second is connective tissue, in particular hypermobile Ehlers-Danlos syndrome (hEDS) and generalised joint hypermobility. In a 2020 study in Autonomic Neuroscience, 31% of 91 POTS patients met clinical criteria for hEDS, with a further quarter showing hypermobility short of the full criteria.5 The leading explanation is that more elastic blood-vessel walls let more blood pool on standing, adding load to the heart-rate response. If you have bendy joints, recurrent sprains or stretchy skin alongside your POTS, mention it to your clinician.

Why POTS gets misdiagnosed as anxiety

This is the part patients find most validating to hear stated plainly. The surface picture of POTS, a racing heart, breathlessness, shakiness, light-headedness, dread, looks almost identical to a panic attack. The autonomic surge is real and the symptoms are real, but the trigger is standing up, not fear. Because most patients are young women, and because routine tests sit lying down come back normal, the symptoms are too often attributed to anxiety.3

The numbers are stark. The average diagnostic delay is close to six years, and only about a quarter of patients are diagnosed within the first year of symptoms.3 In a 2024 outcomes survey published in the Journal of the American Heart Association, 45% of patients had first been diagnosed with an anxiety or panic disorder before POTS was identified.11 None of this means anxiety and POTS cannot coexist; they often do, and living with an unexplained, frightening condition for years is itself anxiety-provoking. The key point is that a normal resting heart trace does not rule POTS out, because POTS reveals itself on standing.

When a fast heart rate needs urgent assessment. POTS is not life-threatening, but a racing heart can have other causes. Seek urgent medical help for chest pain, fainting that causes injury, palpitations with severe breathlessness, or a rapid heartbeat that does not settle when you lie down. These features point away from straightforward POTS and need same-day assessment.

Evidence-based management, honestly framed

There is no cure, but most people improve, often substantially, with a structured approach. The evidence base is patchy, dominated by small trials and expert consensus rather than large randomised studies, so the honest summary is "good directions, modest individual proof". First-line management is non-drug.6

Fluids, salt and compression

Expanding blood volume is the foundation. Guidelines suggest drinking roughly 2 to 3 litres of fluid a day and increasing dietary salt toward 8 to 10 g daily if tolerated, sometimes with salt tablets, to raise circulating volume and blunt the heart-rate surge.16 This is intuitive physiology with limited trial proof, but it is low-cost and widely recommended. It is not appropriate for everyone, so anyone with high blood pressure, heart failure or kidney disease should agree a salt and fluid plan with a clinician first.

Compression garments have some of the better acute evidence. In a randomised crossover study in the Journal of the American College of Cardiology (2021), abdominal and full lower-body compression reduced standing heart rate (from about 109 to 92 bpm) and improved symptoms during tilt testing, with abdominal compression carrying much of the benefit.12 Waist-high (at least 30 to 40 mmHg) or abdominal compression is more useful than knee-high stockings, because much of the pooling is in the abdomen.

Graded recumbent exercise

This is counter-intuitive but among the strongest tools. Exercise intolerance makes people avoid activity, deconditioning follows, and the POTS worsens. Structured reconditioning that starts lying down, using a recumbent bike, rowing machine or swimming, then gradually adds upright work over weeks to months, breaks that cycle. This is the basis of the Levine (Dallas) protocol and the paediatric CHOP adaptation. In Benjamin Levine's group, a three-month graded programme left around 53% of participants no longer meeting POTS criteria, with gains in fitness, heart size and blood volume.13 The catch is that it is hard, often makes you feel worse for the first few weeks, and needs pacing; this is not "push through it".

What the exercise evidence does and does not show. Graded recumbent training reliably improves fitness and reduces orthostatic tachycardia across studies, and is recommended in every major guideline. But trials are small, drop-out is common because the early phase is tough, and it is not a quick fix. For people with co-existing ME/CFS or post-exertional malaise, a far gentler, symptom-titrated approach is essential, because the standard protocol can cause harm if pushed too fast.

Medicines, and the off-label reality

Drugs are added when the basics are not enough. An important honesty point for UK readers: no medicine is currently licensed specifically for POTS, so essentially all drug treatment is off-label or unlicensed, prescribed on clinical judgement and consensus rather than a product licence.6 That is not a reason to avoid them, but you should know it.

Commonly used POTS medicines and the realistic evidence behind them. All are used off-label in the UK; doses and choice must be individualised by a prescriber.
MedicineHow it is meant to helpEvidence and notes
IvabradineSlows the heart's pacemaker directly, without lowering blood pressureSmall randomised crossover trial (Taub 2021, 22 patients, hyperadrenergic POTS) lowered standing heart rate and improved quality of life.14
Beta-blockers (e.g. propranolol)Blunt the heart-rate surge; help hyperadrenergic featuresLow-dose propranolol (about 20 mg) improved heart rate and exercise capacity in a small randomised study; higher doses did not, and can worsen fatigue.15
FludrocortisoneHelps the body retain salt and water, expanding blood volumeUsed for volume expansion; consensus-supported but with limited trial data. Side effects include high blood pressure and low potassium.6
MidodrineTightens blood vessels, reducing pooling on standingImproves orthostatic tachycardia in some patients; side effects include scalp tingling, supine high blood pressure and urinary retention.6

Treatment is matched to the dominant picture: heart-rate-lowering drugs such as ivabradine or low-dose beta-blockers for racing-heart and hyperadrenergic features, volume expanders such as fludrocortisone for low-volume features, and vasoconstrictors such as midodrine for marked pooling. Most regimens combine the non-drug basics with one or two medicines. Before adding supplements such as electrolytes or magnesium on top, it is worth checking for overlap and interactions; our stack builder is built for exactly that.

Getting help in the UK

Start with your GP. Much of POTS can be diagnosed and managed in primary care: an active stand test, basic bloods and an ECG, plus first-line advice on fluids, salt, compression and graded activity. Referral to cardiology, neurology or an autonomic specialist is appropriate where the diagnosis is uncertain, an arrhythmia is suspected, symptoms are severe or first-line measures fail.9 The patient charity PoTS UK is a well-regarded, clinician-reviewed resource with information sheets you can take to appointments.16

What to ask your GP
What to do next

References

  1. Sheldon RS, Grubb BP, Olshansky B, et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm. PMC5267948, 2015.
  2. Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting. Auton Neurosci. PMC8455420, 2021.
  3. Dysautonomia International. Diagnostic Delay in POTS. dysautonomiainternational.org, accessed 2026.
  4. Kavi L, et al; investigators. Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID. Circ Arrhythm Electrophysiol. ahajournals.org, 2025.
  5. Miller AJ, Stiles LE, Sheehan T, et al. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome. Auton Neurosci. PMC7282488, 2020.
  6. Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. cmaj.ca, 2022.
  7. Mar PL, Raj SR. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies. Annu Rev Med. PMC7990114, 2020.
  8. Gunning WT, Kvale H, Kramer PM, et al. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies. J Am Heart Assoc. PMC7914580, 2019.
  9. PoTS UK. Tests and Diagnosis. potsuk.org, accessed 2026.
  10. Fedorowski A, et al. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol. nature.com, 2023.
  11. Shaw BH, Stiles LE, Bourne K, et al. The Long-Term POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes. J Am Heart Assoc. ahajournals.org, 2024.
  12. Bourne KM, Sheldon RS, Hall J, et al. Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome. J Am Coll Cardiol. jacc.org, 2021.
  13. Fu Q, Levine BD. Exercise and non-pharmacological treatment of POTS. Auton Neurosci; and George SA, et al. The international POTS registry: Evaluating the efficacy of an exercise training intervention. PMC5556378, 2018.
  14. Taub PR, Zadourian A, Lo HC, et al. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome. J Am Coll Cardiol. jacc.org, 2021.
  15. Arnold AC, Okamoto LE, Diedrich A, et al. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study. Neurology. PMID 23616163, 2013.
  16. PoTS UK. What is PoTS? potsuk.org, accessed 2026.

This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.